Minimed Group, Inc. MMED
NASDAQ
| 07/31/2026 | 04/24/2026 | 01/23/2026 | 10/24/2025 | 07/25/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -185.00M | -119.00M | -14.50M | -19.00M |
| Total Depreciation and Amortization | 41.00M | 39.00M | 39.00M | 39.00M | 39.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.00M | -36.00M | 124.00M | 29.00M | 27.00M |
| Change in Net Operating Assets | -110.00M | 12.00M | 22.00M | -100.00M | -188.00M |
| Cash from Operations | -49.00M | -170.00M | 66.00M | -46.50M | -141.00M |
| Capital Expenditure | -41.00M | -56.00M | -53.00M | -57.00M | -53.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | -5.00M | -10.00M |
| Cash from Investing | -41.00M | -56.00M | -53.00M | -62.00M | -63.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 538.00M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -229.00M | -- | -- | -- |
| Other Financing Activities | -- | 203.00M | -11.00M | 107.50M | 202.00M |
| Cash from Financing | -- | 512.00M | -11.00M | 107.50M | 202.00M |
| Foreign Exchange rate Adjustments | -1.00M | 1.00M | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 1.00M | -1.00M | -- | -- |
| Net Change in Cash | -91.00M | 288.00M | 1.00M | -1.00M | -2.00M |